Status:
NOT_YET_RECRUITING
Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Avoidant/Restrictive Food Intake Disorder (ARFID)
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Avoidant/restrictive food intake disorder (ARFID) is a serious and impairing eating disorder - occurring in up to 4% of adults - for which most individuals do not have access to treatment. The propose...
Eligibility Criteria
Inclusion
- Current avoidant/restrictive food intake disorder based on DSM-5 criteria
- Must not have completed face-to-face CBT-AR at the Eating Disorders Clinical and Research Program at Massachusetts General Hospital
- Ability to speak, write, and understand English
- Residence in the United States
- Access to an internet-connected smartphone device
Exclusion
- Underweight status (i.e., BMI \< 18.5 kg/m2)
- Complete lack of oral intake or dependence on supplemental feeding
- Feeding or eating disorder other than ARFID
- Any comorbid clinically significant disorder that would require attention beyond the study treatment
- 6\. Medical instability requiring inpatient care according to the American Psychiatric Association 2023 treatment guidelines for eating disorders 7. Medical history of intellectual disability 8. Illiteracy
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2030
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06898177
Start Date
April 1 2025
End Date
April 1 2030
Last Update
April 4 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.